Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients

Radiotherapy and Oncology

Volumn 78, Issue 1, 2006, Pages 60-66

  Syeda, Bonni ^a   Schukro, Christoph ^a   Kirisits, Christian ^a   Lang, Irene ^a   Siostrzonek, Peter ^a   Gottsauner Wolf, Michael ^a   Pokrajac, Boris ^a   Schmid, Rainer ^a   Yahya, Nabil ^a   Pötter, Richard ^a   Glogar, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Coronary artery disease; Diabetic mellitus; Intracoronary brachytherapy; Intracoronary radiation; Stent implantation

Indexed keywords

BETA-CATH; PLACEBO; STRONTIUM 90; YTTRIUM 90;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETIC PATIENT; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; THROMBOSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BETA RAYS; BRACHYTHERAPY; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEIN IIB; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STENTS; STRONTIUM RADIOISOTOPES; TREATMENT OUTCOME; YTTRIUM;

EID: 31144455819     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.10.012     Document Type: Article

References (31)

1. J.A. Beckman, M.A. Creager, and P. Libby Diabetes and atherosclerosis: epidemiology, pathophysiology, and management J Am Med Assoc 287 2002 2570 2581
2. L.M. Rasmussen, and T. Ledet Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total to cyanogen bromide solubilisation Diabetologia 36 1993 445 453
3. S.L. Mautner, F. Lin, and W.C. Roberts Composition of atherosclerotic plaques in the epicardial coronary arteries in juvenile (type I) diabetes mellitus Am J Cardiol 70 1992 1264 1268
4. M.A. Creager, T.F. Luscher, and F. Cosentino Beckman JA.Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy Circulation 108 2003 1527 1532
5. B. Stein, W.S. Weintraub, and S.P. Gebhart Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty Circulation 91 1995 979 989
6. S. MacRury, and G. Lowe Blood rheology in diabetes mellitus Diabet Med 7 1990 285 291
7. H. Breddin, H. Krzywanek, P. Althoff, K. Schoffling, and K. Ubeila PARD: platelet aggregation as a risk factor in diabetes - results of a prospective study Horm Metab Res 15 1985 63 68
8. D. Aronson, Z. Bloomgarden, and E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J Am Coll Cardiol 27 1996 528 535
9. E. Van Belle, C. Bauters, and E. Hubert Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels Circulation 96 1997 1454 1460
10. K.E. Kip, D.P. Faxon, K.M. Detre, W. Yeh, S.F. Kelsey, and J.W. Currier Coronary angioplasty in diabetic patients. The national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry Circulation 94 1996 1818 1825
11. J.P. Carrozza Jr, R.E. Kuntz, R.F. Fishman, and D.S. Baim Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus Ann Intern Med 118 1993 344 349
12. K.W. Lau, Z.P. Ding, A. Johan, and Y.L. Lim Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study Am Heart J 136 1998 150 155
13. P.S. Teirstein, V. Massullo, and S. Jani Catheter-based radiotherapy to inhibit restenosis after coronary stenting N Engl J Med 336 1997 1697 1703
14. A.E. Raizner, S.N. Oesterle, and R. Waksman Inhibition of restenosis with beta-emitting radiotherapy: report of the proliferation reduction with vascular energy trial (PREVENT) Circulation 102 2000 951 958
15. P.S. Teirstein, V. Massullo, and S. Jani Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial Circulation 101 2000 360 365
16. R. Waksman, A.E. Raizner, A.C. Yeung, A.J. Lansky, and L. Vandertie Use of localized intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomized controlled trial Lancet 359 2002 551 557
17. B. Pokrajac, R. Potter, and R.M. Wolfram Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study Radiother Oncol 74 2005 3 9
18. L. Gruberg, R. Waksman, and A.E. Ajani The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus J Am Coll Cardiol 39 2002 1930 1936
19. J.W. Moses, I. Moussa, and M.B. Leon Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial) Am J Cardiol 90 2002 243 247
20. B. Syeda, P. Siostrzonek, and R. Schmid Geographical miss during intracoronary irradiation: impact on restenosis and determination of required safety margin length J Am Coll Cardiol 40 2002 1225 1231
21. R. Schmid, C. Kirisits, and B. Syeda Quality assurance in intracoronary brachytherapy. Recommendations for determining the planning target length to avoid geographic miss Radiother Oncol 71 2004 311 318
22. C. Kirisits, D. Georg, P. Wexberg, B. Pokrajac, D. Glogar, and R. Pötter Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices Radiother Oncol 64 2002 309 315
23. C. Kirisits, A. Stemberger, B. Pokrajac, D. Glogar, R. Potter, and D. Georg Clinical quality assurance for endovascular brachytherapy devices Radiother Oncol 71 2004 91 98
24. M. Sabate, G. Pimentel, and C. Prieto Intracoronary brachytherapy after stenting de novo lesions in diabetic patients J Am Coll Cardiol 44 2004 520 527
25. R. Waksman, A.E. Ajani, and R.L. White Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation 109 2004 340 344
26. R. Waksman, A.E. Ajani, and E. Pinnow Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS Circulation 106 2002 776 778
27. M.A. Grise, V. Massullo, and S. Jani Five-year clinical follow-up after intracoronary radiation: results of a randomized clinical trial Circulation 105 2002 2737 2740
28. R. Waksman, R.L. White, and R.C. Chan Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis Circulation 101 2000 2165 2171
29. R. Waksman, B. Bhargava, and L. White Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis Circulation 101 2000 1895 1898
30. P.W. Serruys, W. Wijns, and G. Sianos Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE) J Am Coll Cardiol 44 2004 528 537
31. P.W. Serruys, G. Sianos, and W. van der Giessen Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study Eur Heart J 23 2002 1351 1359